In addition, other studies have shown that transmembrane 6 superfamily 2 (TM6SF2 rs58542926 C>T) and hydroxysteroid 17-beta dehydrogenase 13 (HSD17B13 rs9992651 G>A) are also associated with NAFLD development [18,20,21,22]. Here, HSD17B13 is linked to metabolic dysfunction-associated steatotic liver disease.